3 Questions: Jeffrey Harris on why we still don't have an HIV vaccine

While many vaccines used around the world today are produced for profit by commercial firms, the private sector accounts for a tiny fraction of the funding for an HIV vaccine: 4 percent in 2008, down from 9 percent in 2007, according to Jeffrey Harris, an MD as well as a professor in MIT`s Department of Economics. Harris, who has long studied health issues, contends in a new issue of the journal Health Affairs that the private sector should be given significantly more incentives to help develop an HIV vaccine.

Read the whole article on Physorg

More from Physorg